O'Shaughnessy Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22M Buy
159,427
+55,498
+53% +$1.12M 0.01% 709
2026
Q1
$2.04M Buy
103,929
+16,746
+19% +$410K 0.01% 867
2025
Q4
$2.33M Buy
87,183
+18,125
+26% +$467K 0.01% 773
2025
Q3
$1.84M Buy
69,058
+28,749
+71% +$742K 0.01% 861
2025
Q2
$925K Buy
+40,309
New +$1M 0.01% 1088
2024
Q1
– Sell
-4,228
Closed -$262K – 1876
2023
Q4
$262K Buy
+4,228
New +$222K ﹤0.01% 1274
2020
Q1
– Sell
-143
Closed -$3K – 1304
2019
Q4
$3K Buy
+143
New +$2.74K ﹤0.01% 1551

Other funds holding AMPH

O'Shaughnessy Asset Management's AMPH Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Amphastar Pharmaceuticals (AMPH) stake by 53% in Q2 2026, buying an estimated $1.12M and bringing the position to 159,427 shares worth $3.22M. The position accounts for 0.01% of the portfolio, ranked #709.

O'Shaughnessy Asset Management first reported a position in AMPH in Q4 2019 and has held it in 7 quarters since. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • O'Shaughnessy Asset Management held 159,427 shares of Amphastar Pharmaceuticals worth $3.22M as of Q2 2026.
  • O'Shaughnessy Asset Management bought 55,498 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
  • Amphastar Pharmaceuticals made up 0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #709 holding.
  • O'Shaughnessy Asset Management first reported a position in Amphastar Pharmaceuticals in Q4 2019 and has held it in 7 quarters since.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.